Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-02-001357
Filing Date
2002-11-07
Accepted
2002-11-06 21:29:36
Documents
7
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDED 9-30-02 a85510e10vq.htm 10-Q 135592
3 EXHIBIT 10.46 a85510exv10w46.txt EX-10.46 6246
4 EXHIBIT 10.47 a85510exv10w47.txt EX-10.47 6234
5 EXHIBIT 10.48 a85510exv10w48.txt EX-10.48 26009
6 EXHIBIT 10.49 a85510exv10w49.txt EX-10.49 10181
7 EXHIBIT 10.50 a85510exv10w50.txt EX-10.50 1682
8 EXHIBIT 99.1 a85510exv99w1.txt EX-99.1 1830
  Complete submission text file 0000936392-02-001357.txt   190005
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 02811767
SIC: 2836 Biological Products, (No Diagnostic Substances)